US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 269.810
  • -3.740-1.37%
Close May 6 16:00 ET
  • 269.420
  • -0.390-0.14%
Pre 04:01 ET
35.18BMarket Cap-128.48P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-45.14%-118.31M
-107.98%-8.31M
-217.71%-94.66M
-87.84%43.71M
310.49%124.16M
51.03%-81.52M
119.24%104.16M
77.42%-29.8M
411.76%359.41M
51.97%-58.99M
Net income from continuing operations
12.82%-57.48M
36.82%-278.16M
39.24%-83.76M
-175.51%-111.57M
93.88%-16.89M
62.13%-65.94M
61.08%-440.24M
33.55%-137.87M
136.40%147.75M
0.50%-276.02M
Operating gains losses
585.90%58.89M
61.01%173.79M
215.37%70.44M
-21.26%37.84M
97.57%56.93M
-1.74%8.59M
-47.23%107.94M
30.71%22.34M
-56.12%48.05M
-12.70%28.82M
Depreciation and amortization
6.57%14.41M
4.84%56.67M
-8.11%-20.55M
14.90%27.04M
56.36%36.66M
-48.17%13.52M
21.56%54.05M
-17.33%-19M
13.96%23.53M
15.86%23.45M
Deferred tax
2,023.13%9.64M
-14,873.63%-106.76M
----
----
----
--454K
50.24%-713K
----
----
----
Other non cash items
-37.70%15.61M
-15.39%88.15M
180.65%28.54M
-72.60%13.87M
-15.21%20.69M
31.86%25.05M
0.15%104.18M
167.96%10.17M
82.75%50.61M
-34.83%24.4M
Change In working capital
-100.12%-217.05M
-473.87%-214.08M
-239.25%-74.21M
20.38%30.73M
-196.23%-62.14M
-25.91%-108.46M
651.65%57.26M
80.68%53.29M
448.47%25.53M
93.17%64.58M
-Change in receivables
-1,913.17%-7.43M
1.58%-86.55M
-1,638.07%-59.51M
65.65%-37.09M
424.58%9.64M
-97.86%410K
-92.86%-87.94M
107.26%3.87M
-181.06%-107.99M
-146.41%-2.97M
-Change in inventory
28,150.00%6.22M
-26.01%13.59M
-92.92%849K
23.57%5.93M
242.27%6.79M
105.46%22K
153.81%18.37M
163.18%11.99M
160.82%4.8M
121.58%1.99M
-Change in prepaid assets
56.58%-32.77M
135.76%3.23M
8.05%25.28M
-149.46%-8.28M
321.31%61.69M
-6,010.28%-75.46M
76.55%-9.03M
169.34%23.4M
-183.68%-3.32M
-30.82%-27.87M
-Change in payables and accrued expense
-3,101.17%-155.74M
12.68%91.09M
-60.62%-62.11M
-29.60%83.6M
-10.00%74.47M
94.07%-4.87M
-57.85%80.84M
-137.68%-38.67M
70.25%118.74M
21.42%82.74M
-Change in other current liabilities
----
----
----
-25.78%-14.05M
0.63%-10.95M
-0.10%-12.84M
----
----
-8.59%-11.17M
-2.40%-11.02M
-Change in other working capital
4.35%-27.32M
-527.91%-235.45M
-193.64%-16.56M
-97.45%624K
-979.27%-190.94M
-222.75%-28.56M
183.48%55.02M
142.85%17.69M
296.29%24.47M
13,644.30%21.72M
Cash from discontinued investing activities
Operating cash flow
-45.14%-118.31M
-107.98%-8.31M
-217.71%-94.66M
-87.84%43.71M
310.49%124.16M
51.03%-81.52M
119.24%104.16M
77.42%-29.8M
411.76%359.41M
51.97%-58.99M
Investing cash flow
Cash flow from continuing investing activities
268.25%113.77M
65.26%-116.84M
78.01%-52.91M
-181.03%-30.25M
489.53%33.94M
11.28%-67.62M
-298.61%-336.35M
-72.01%-240.66M
-103.43%-10.76M
-106.10%-8.71M
Net PPE purchase and sale
30.86%-8.97M
44.90%-34.28M
40.60%-9.09M
75.47%-4.19M
49.63%-8.02M
6.61%-12.97M
13.67%-62.21M
29.24%-15.31M
-3.53%-17.09M
0.85%-15.92M
Net investment purchase and sale
324.60%122.74M
76.55%-63.25M
80.61%-43.7M
-163.70%-6.86M
482.26%41.96M
12.32%-54.65M
-205.93%-269.7M
-89.91%-225.35M
-96.79%10.77M
-95.69%7.21M
Net other investing changes
----
-335.26%-19.32M
---117K
----
----
----
66.36%-4.44M
--0
----
----
Cash from discontinued investing activities
Investing cash flow
268.25%113.77M
65.26%-116.84M
78.01%-52.91M
-181.03%-30.25M
489.53%33.94M
11.28%-67.62M
-298.61%-336.35M
-72.01%-240.66M
-103.43%-10.76M
-106.10%-8.71M
Financing cash flow
Cash flow from continuing financing activities
52.48%44.08M
70.89%294.16M
-20.98%31M
210.08%102.76M
146.27%131.5M
-37.65%28.91M
-59.57%172.13M
-38.16%39.23M
-88.84%33.14M
76.00%53.39M
Net issuance payments of debt
----
--0
----
----
----
----
--0
----
----
----
Proceeds from stock option exercised by employees
90.90%49.37M
105.44%302.95M
17.43%36.28M
335.54%108.04M
168.81%132.78M
-38.97%25.86M
-43.14%147.46M
-45.53%30.89M
-83.79%24.81M
119.50%49.39M
Net other financing activities
-273.03%-5.28M
-135.64%-8.79M
-163.37%-5.28M
-163.37%-5.28M
-132.05%-1.28M
-23.70%3.05M
128.16%24.67M
107.50%8.33M
6.38%8.33M
-48.94%4M
Cash from discontinued financing activities
Financing cash flow
52.48%44.08M
70.89%294.16M
-20.98%31M
210.08%102.76M
146.27%131.5M
-37.65%28.91M
-59.57%172.13M
-38.16%39.23M
-88.84%33.14M
76.00%53.39M
Net cash flow
Beginning cash position
18.87%968.65M
-6.18%814.88M
6.50%1.1B
47.16%971.19M
1.53%684.72M
-6.18%814.88M
5.64%868.56M
-3.74%1.04B
14.24%659.98M
25.76%674.41M
Current changes in cash
132.89%39.54M
381.38%169.01M
49.58%-116.58M
-69.56%116.21M
2,124.43%289.59M
38.76%-120.22M
-211.57%-60.06M
-10.92%-231.22M
-22.97%381.79M
-128.43%-14.31M
Effect of exchange rate changes
241.41%14.06M
-338.44%-15.24M
-258.49%-17.27M
330.36%15.09M
-2,300.00%-3.12M
-556.85%-9.94M
186.02%6.39M
573.07%10.9M
-423.72%-6.55M
98.53%-130K
End cash Position
49.29%1.02B
18.87%968.65M
18.87%968.65M
6.50%1.1B
47.16%971.19M
1.53%684.72M
-6.18%814.88M
-6.18%814.88M
-3.74%1.04B
14.24%659.98M
Free cash flow
-34.71%-127.28M
-201.54%-42.59M
-130.04%-103.76M
-88.46%39.52M
255.05%116.14M
47.61%-94.49M
106.84%41.95M
70.64%-45.1M
359.74%342.32M
46.06%-74.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -45.14%-118.31M-107.98%-8.31M-217.71%-94.66M-87.84%43.71M310.49%124.16M51.03%-81.52M119.24%104.16M77.42%-29.8M411.76%359.41M51.97%-58.99M
Net income from continuing operations 12.82%-57.48M36.82%-278.16M39.24%-83.76M-175.51%-111.57M93.88%-16.89M62.13%-65.94M61.08%-440.24M33.55%-137.87M136.40%147.75M0.50%-276.02M
Operating gains losses 585.90%58.89M61.01%173.79M215.37%70.44M-21.26%37.84M97.57%56.93M-1.74%8.59M-47.23%107.94M30.71%22.34M-56.12%48.05M-12.70%28.82M
Depreciation and amortization 6.57%14.41M4.84%56.67M-8.11%-20.55M14.90%27.04M56.36%36.66M-48.17%13.52M21.56%54.05M-17.33%-19M13.96%23.53M15.86%23.45M
Deferred tax 2,023.13%9.64M-14,873.63%-106.76M--------------454K50.24%-713K------------
Other non cash items -37.70%15.61M-15.39%88.15M180.65%28.54M-72.60%13.87M-15.21%20.69M31.86%25.05M0.15%104.18M167.96%10.17M82.75%50.61M-34.83%24.4M
Change In working capital -100.12%-217.05M-473.87%-214.08M-239.25%-74.21M20.38%30.73M-196.23%-62.14M-25.91%-108.46M651.65%57.26M80.68%53.29M448.47%25.53M93.17%64.58M
-Change in receivables -1,913.17%-7.43M1.58%-86.55M-1,638.07%-59.51M65.65%-37.09M424.58%9.64M-97.86%410K-92.86%-87.94M107.26%3.87M-181.06%-107.99M-146.41%-2.97M
-Change in inventory 28,150.00%6.22M-26.01%13.59M-92.92%849K23.57%5.93M242.27%6.79M105.46%22K153.81%18.37M163.18%11.99M160.82%4.8M121.58%1.99M
-Change in prepaid assets 56.58%-32.77M135.76%3.23M8.05%25.28M-149.46%-8.28M321.31%61.69M-6,010.28%-75.46M76.55%-9.03M169.34%23.4M-183.68%-3.32M-30.82%-27.87M
-Change in payables and accrued expense -3,101.17%-155.74M12.68%91.09M-60.62%-62.11M-29.60%83.6M-10.00%74.47M94.07%-4.87M-57.85%80.84M-137.68%-38.67M70.25%118.74M21.42%82.74M
-Change in other current liabilities -------------25.78%-14.05M0.63%-10.95M-0.10%-12.84M---------8.59%-11.17M-2.40%-11.02M
-Change in other working capital 4.35%-27.32M-527.91%-235.45M-193.64%-16.56M-97.45%624K-979.27%-190.94M-222.75%-28.56M183.48%55.02M142.85%17.69M296.29%24.47M13,644.30%21.72M
Cash from discontinued investing activities
Operating cash flow -45.14%-118.31M-107.98%-8.31M-217.71%-94.66M-87.84%43.71M310.49%124.16M51.03%-81.52M119.24%104.16M77.42%-29.8M411.76%359.41M51.97%-58.99M
Investing cash flow
Cash flow from continuing investing activities 268.25%113.77M65.26%-116.84M78.01%-52.91M-181.03%-30.25M489.53%33.94M11.28%-67.62M-298.61%-336.35M-72.01%-240.66M-103.43%-10.76M-106.10%-8.71M
Net PPE purchase and sale 30.86%-8.97M44.90%-34.28M40.60%-9.09M75.47%-4.19M49.63%-8.02M6.61%-12.97M13.67%-62.21M29.24%-15.31M-3.53%-17.09M0.85%-15.92M
Net investment purchase and sale 324.60%122.74M76.55%-63.25M80.61%-43.7M-163.70%-6.86M482.26%41.96M12.32%-54.65M-205.93%-269.7M-89.91%-225.35M-96.79%10.77M-95.69%7.21M
Net other investing changes -----335.26%-19.32M---117K------------66.36%-4.44M--0--------
Cash from discontinued investing activities
Investing cash flow 268.25%113.77M65.26%-116.84M78.01%-52.91M-181.03%-30.25M489.53%33.94M11.28%-67.62M-298.61%-336.35M-72.01%-240.66M-103.43%-10.76M-106.10%-8.71M
Financing cash flow
Cash flow from continuing financing activities 52.48%44.08M70.89%294.16M-20.98%31M210.08%102.76M146.27%131.5M-37.65%28.91M-59.57%172.13M-38.16%39.23M-88.84%33.14M76.00%53.39M
Net issuance payments of debt ------0------------------0------------
Proceeds from stock option exercised by employees 90.90%49.37M105.44%302.95M17.43%36.28M335.54%108.04M168.81%132.78M-38.97%25.86M-43.14%147.46M-45.53%30.89M-83.79%24.81M119.50%49.39M
Net other financing activities -273.03%-5.28M-135.64%-8.79M-163.37%-5.28M-163.37%-5.28M-132.05%-1.28M-23.70%3.05M128.16%24.67M107.50%8.33M6.38%8.33M-48.94%4M
Cash from discontinued financing activities
Financing cash flow 52.48%44.08M70.89%294.16M-20.98%31M210.08%102.76M146.27%131.5M-37.65%28.91M-59.57%172.13M-38.16%39.23M-88.84%33.14M76.00%53.39M
Net cash flow
Beginning cash position 18.87%968.65M-6.18%814.88M6.50%1.1B47.16%971.19M1.53%684.72M-6.18%814.88M5.64%868.56M-3.74%1.04B14.24%659.98M25.76%674.41M
Current changes in cash 132.89%39.54M381.38%169.01M49.58%-116.58M-69.56%116.21M2,124.43%289.59M38.76%-120.22M-211.57%-60.06M-10.92%-231.22M-22.97%381.79M-128.43%-14.31M
Effect of exchange rate changes 241.41%14.06M-338.44%-15.24M-258.49%-17.27M330.36%15.09M-2,300.00%-3.12M-556.85%-9.94M186.02%6.39M573.07%10.9M-423.72%-6.55M98.53%-130K
End cash Position 49.29%1.02B18.87%968.65M18.87%968.65M6.50%1.1B47.16%971.19M1.53%684.72M-6.18%814.88M-6.18%814.88M-3.74%1.04B14.24%659.98M
Free cash flow -34.71%-127.28M-201.54%-42.59M-130.04%-103.76M-88.46%39.52M255.05%116.14M47.61%-94.49M106.84%41.95M70.64%-45.1M359.74%342.32M46.06%-74.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +29.96%
Sample Name
Sample Code
 +25.11%
Sample Name
Sample Code
 +21.20%
4
Jiangsu Olive Sensors High-Tech
300507
+20.05%
5
Jing-Jin Electric Technologies
688280
+20.05%
Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More
Berkshire's 2025 Annual Shareholders Meeting

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 127.660
Sample Name
Sample Code
 382.980
Sample Name
Sample Code
 139.900
4
Netflix
NFLX
1137.690
5
Salesforce
CRM
273.360
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 10.920
Sample Name
Sample Code
 6.500
Sample Name
Sample Code
 3.120
4
Mawson Infrastructure
MIGI
0.5980
5
Cipher Mining
CIFR
3.040
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -